Jazz and AbCellera sign deal for T-cell engagers in solid tumours
AbCellera will conduct discovery and early-stage research activities on two initial programmes.
Drug Development
LG AI Research and D&D Pharmatech sign agreement for oral peptide drugs
AviadoBio broadens vMiX gene silencing licence with King’s College London
Zai Lab’s zocilurtatug pelitecan secures EMA orphan drug status
Alkermes’ alixorexton secures FDA and EC orphan designations
Simcere and Stanford partner to develop IPF therapies
FDA clears MSD’s Keytruda combo plus Welireg for ccRCC treatment
China’s NMPA approves Akeso’s gumokimab for plaque psoriasis
